Orilissa
Showing 1 - 14 of 14
Polycystic Ovary Syndrome Trial in Puerto Rico, United States (Elagolix, Placebo)
Ovulation; Failure or Lack of Trial (Elagolix 200 MG Oral Tablet [Orilissa])
Unknown status
- Ovulation; Failure or Lack of
- Elagolix 200 MG Oral Tablet [Orilissa]
- (no location specified)
Aug 14, 2019
Endometriosis, Unexplained Infertility Trial in Winston-Salem (Elagolix, Oral Contraceptive)
Recruiting
- Endometriosis
- Unexplained Infertility
- Elagolix
- Oral Contraceptive
-
Winston-Salem, North CarolinaWake Forest Univesity Health Sciences
Dec 1, 2022
Oral Elagolix Tablets To Assess Tolerability and Change in
Recruiting
- Endometriosis
-
Ramat Gan, Tel-Aviv, Israel
- +7 more
Jun 8, 2022
Endometriosis Trial (Leuprorelin Acetate Depot, Elagolix, Placebo to Elagolix)
Completed
- Endometriosis
- Leuprorelin Acetate Depot
- +3 more
- (no location specified)
Aug 9, 2018
Pregnancy Outcomes in Females Treated With Oral Elagolix Tablets
Recruiting
- Endometriosis
- Uterine Fibrioids
-
Durham, North CarolinaIqvia /Id# 240918
Mar 8, 2022
Endometriosis Trial in Canada, Puerto Rico, United States (Estradiol/Norethindrone Acetate, Placebo for Elagolix, Elagolix)
Active, not recruiting
- Endometriosis
- Estradiol/Norethindrone Acetate
- +3 more
-
Birmingham, Alabama
- +196 more
Feb 14, 2022